Welcome to LookChem.com Sign In|Join Free
  • or
3-(cyclohexylmethyl)isoquinoline is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1070667-80-9

Post Buying Request

1070667-80-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1070667-80-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1070667-80-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,7,0,6,6 and 7 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1070667-80:
(9*1)+(8*0)+(7*7)+(6*0)+(5*6)+(4*6)+(3*7)+(2*8)+(1*0)=149
149 % 10 = 9
So 1070667-80-9 is a valid CAS Registry Number.

1070667-80-9Upstream product

1070667-80-9Downstream Products

1070667-80-9Relevant academic research and scientific papers

Synthesis of Polysubstituted Isoquinolines and Related Fused Pyridines from Alkenyl Boronic Esters via a Copper-Catalyzed Azidation/Aza-Wittig Condensation Sequence

Jayaram, Vankudoth,Sridhar, Tailor,Sharma, Gangavaram V. M.,Berrée, Fabienne,Carboni, Bertrand

, p. 843 - 853 (2018)

An efficient and straightforward synthesis of isoquinolines is reported from internal alkenyl boronic esters, easily prepared from the corresponding 1,2-bis(boronates), via a sequential copper-catalyzed azidation/aza-Wittig condensation. This synthetic method has been used to synthesize quinisocaine, a topical anesthetic used for the treatment of pain and pruritus, and further extended to thieno[2,3-c]pyridines by using 2-thiophenecarboxaldehyde as coupling partner in the first step.

TETRAHYDROISOQUINOLINE COMPOUND

-

Page/Page column 55, (2010/01/29)

The present invention relates a specific tetrahydroisoquinoline compound which is useful as a chemokine receptor type 3 (CCR3) antagonist, and a pharmaceutical composition comprising the same as an active ingredient. The tetrahydroisoquinoline compound of the present invention is useful for the treatment or prevention of a disease in which CCR3 participates.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1070667-80-9